Recent Quotes (30 days)

You have no recent quotes
chg | %

Hutchison China MediTech Limited  

(Public, LON:HCM)   Watch this stock  
Find more results forHCM
3,030.00
+47.50 (1.59%)
Mar 23 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 2,975.00 - 3,070.00
52 week 1,612.50 - 3,335.71
Open 2,992.50
Vol / Avg. 6,669.00/16,867.00
Mkt cap 1,793.22M*
P/E 196.37
Div/yield     -
EPS 0.15*
Shares 60.71M
Beta     -
Inst. own     -
*GBP
Mar 13, 2017
Full Year 2016 Hutchison China MediTech Ltd Earnings Release (Estimated)
  

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 10.54% 6.74%
Operating margin -27.55% -21.61%
EBITD margin - -20.53%
Return on average assets 7.05% 5.09%
Return on average equity 12.27% 8.74%
CDP Score - -

Address


+85221281188 (Phone)
+85221281778 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.

Officers and directors

Simon To Executive Chairman of the Board
Age: 63
Christian Hogg Chief Executive Officer, Executive Director
Age: 49
Chig Fung Cheng Chief Financial Officer, Executive Director
Age: 48
Edith Shih Company Secretary, Non-Executive Director
Age: 64
Dan Eldar Non-Executive Director
Age: 62
Paul Rutherford Carter Senior Independent Non-Executive Director
Age: 56
Karen Jean Ferrante M.D. Non-Executive Independent Director
Age: 59
Graeme Allan Jack Independent Non-Executive Director
Age: 66